Live
- No more smoking in government office premises
- Google Cloud unveils new initiatives to empower AI startups in India
- Collector Warns of Strict Action if Irregularities Occur in Weighing Process
- WPL 2025: Mumbai Indians release Issy Wong, Humairaa Kaazi, Fatima Jaffer and Priyanka Bala
- People will not forgive Congress for repeatedly insulting Constitution: Kiren Rijiju
- Aid group resumes activities at famine-hit camp in Sudan
- Kishan Reddy Vows to End BRS and Congress Influence in Telangana, Criticizes CM's Governance
- Punjab bypolls: Bittu twisting words for political gains, says Congress nominee
- Punjab CM to administer oath to over 10,000 sarpanches on Friday
- BJP Core Committee Plans Protests Against State Government’s Failures
Pandemic is far from over: WHO
The coronavirus pandemic is not even close to being over, said WHO Director-General Tedros Adhanom Ghebreyesus while adding that about 1,80,000 people worldwide have tested positive in the last 24 hours
London: The coronavirus pandemic is not even close to being over, said WHO Director-General Tedros Adhanom Ghebreyesus while adding that about 1,80,000 people worldwide have tested positive in the last 24 hours.
"The reality is this is not close to being over... Globally, the pandemic is actually speeding up," Tedros said.
He said, "For many of our countries to really not hunt down this virus is our failure in contact tracing, because we have lame excuses, saying it's too many and it's too difficult to trace."
Tedros also said that the WHO would be sending a team to Wuhan next week to investigate the potential animal source of the new coronavirus.
Meanwhile, a combination of antiviral drugs commonly used to treat HIV showed no beneficial effects in patients hospitalised with Covid-19 in a large-scale randomised trial, scientists in the UK have found.
The findings "convincingly rule out any meaningful mortality benefit of lopinavir-ritonavir in the hospitalised COVID-19 patients we studied," the scientists running the RECOVERY trial at the University of Oxford said in a statement on Monday.
In March, the RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19, including lopinavir-ritonavir, an antiviral treatment commonly used to treat HIV.
Over 11,800 patients have been enrolled from 176 NHS hospitals in the UK for the trial.
